Clinical Trial Update: Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating atezolizumab monotherapy and subsequent therapy with atezolizumab plus bevacizumab for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN